Does the media prefer LMAT or TFX?

In the previous week, Teleflex had 10 more articles in the media than LeMaitre Vascular. MarketBeat recorded 24 mentions for Teleflex and 14 mentions for LeMaitre Vascular. Teleflex's average media sentiment score of 0.71 beat LeMaitre Vascular's score of 0.12 indicating that Teleflex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral Teleflex 7 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer LMAT or MMED?

In the previous week, LeMaitre Vascular had 12 more articles in the media than MiniMed Group. MarketBeat recorded 14 mentions for LeMaitre Vascular and 2 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 0.94 beat LeMaitre Vascular's score of 0.12 indicating that MiniMed Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral MiniMed Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer LIVN or LMAT?

In the previous week, LeMaitre Vascular had 8 more articles in the media than LivaNova. MarketBeat recorded 14 mentions for LeMaitre Vascular and 6 mentions for LivaNova. LivaNova's average media sentiment score of 0.79 beat LeMaitre Vascular's score of 0.12 indicating that LivaNova is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings and valuation, ITGR or LMAT?

Integer has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.30 $102.81M $3.66 34.23 LeMaitre Vascular $249.60M 7.42 $57.73M $2.85 28.41

Does the media prefer ITGR or LMAT?

In the previous week, LeMaitre Vascular had 6 more articles in the media than Integer. MarketBeat recorded 14 mentions for LeMaitre Vascular and 8 mentions for Integer. Integer's average media sentiment score of 0.65 beat LeMaitre Vascular's score of 0.12 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor IRTC or LMAT?

In the previous week, iRhythm Technologies had 20 more articles in the media than LeMaitre Vascular. MarketBeat recorded 34 mentions for iRhythm Technologies and 14 mentions for LeMaitre Vascular. iRhythm Technologies' average media sentiment score of 0.59 beat LeMaitre Vascular's score of 0.12 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 10 Very Positive mention(s) 5 Positive mention(s) 11 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive LeMaitre Vascular 1 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Neutral

LeMaitre Vascular (LMAT) Competitors

$80.96 -1.88 (-2.27%)

As of 02:03 PM Eastern

Compare

LMAT vs. TFX, MMED, LIVN, ITGR, and IRTC

Should you buy LeMaitre Vascular stock or one of its competitors? LeMaitre Vascular's main competitors and comparable companies include Teleflex (TFX), MiniMed Group (MMED), LivaNova (LIVN), Integer (ITGR), and iRhythm Technologies (IRTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does LeMaitre Vascular compare to Teleflex?

LeMaitre Vascular (NASDAQ:LMAT) and Teleflex (NYSE:TFX) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

LeMaitre Vascular has higher earnings, but lower revenue than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	7.42	$57.73M	$2.85	28.41
Teleflex	$2.25B	2.51	-$905.64M	-$23.29	N/A

In the previous week, Teleflex had 10 more articles in the media than LeMaitre Vascular. MarketBeat recorded 24 mentions for Teleflex and 14 mentions for LeMaitre Vascular. Teleflex's average media sentiment score of 0.71 beat LeMaitre Vascular's score of 0.12 indicating that Teleflex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teleflex	7 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 7.4% of LeMaitre Vascular shares are owned by company insiders. Comparatively, 0.7% of Teleflex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

LeMaitre Vascular currently has a consensus target price of $110.60, indicating a potential upside of 36.61%. Teleflex has a consensus target price of $151.80, indicating a potential upside of 13.86%. Given LeMaitre Vascular's stronger consensus rating and higher possible upside, analysts plainly believe LeMaitre Vascular is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.44
Teleflex	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

LeMaitre Vascular pays an annual dividend of $1.00 per share and has a dividend yield of 1.2%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.0%. LeMaitre Vascular pays out 35.1% of its earnings in the form of a dividend. Teleflex pays out -5.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LeMaitre Vascular has raised its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

LeMaitre Vascular has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

LeMaitre Vascular has a net margin of 25.02% compared to Teleflex's net margin of -39.67%. LeMaitre Vascular's return on equity of 15.63% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	25.02%	15.63%	10.06%
Teleflex	-39.67%	11.93%	5.44%

Summary

LeMaitre Vascular beats Teleflex on 12 of the 19 factors compared between the two stocks.

How does LeMaitre Vascular compare to MiniMed Group?

LeMaitre Vascular (NASDAQ:LMAT) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

LeMaitre Vascular presently has a consensus price target of $110.60, suggesting a potential upside of 36.61%. MiniMed Group has a consensus price target of $21.62, suggesting a potential upside of 6.06%. Given LeMaitre Vascular's higher possible upside, equities research analysts plainly believe LeMaitre Vascular is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.44
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, LeMaitre Vascular had 12 more articles in the media than MiniMed Group. MarketBeat recorded 14 mentions for LeMaitre Vascular and 2 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 0.94 beat LeMaitre Vascular's score of 0.12 indicating that MiniMed Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiniMed Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

84.6% of LeMaitre Vascular shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

LeMaitre Vascular has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	7.42	$57.73M	$2.85	28.41
MiniMed Group	$3.10B	1.85	-$333M	-$0.68	N/A

LeMaitre Vascular has a net margin of 25.02% compared to MiniMed Group's net margin of 0.00%. LeMaitre Vascular's return on equity of 15.63% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	25.02%	15.63%	10.06%
MiniMed Group	N/A	N/A	N/A

Summary

LeMaitre Vascular beats MiniMed Group on 11 of the 15 factors compared between the two stocks.

How does LeMaitre Vascular compare to LivaNova?

LivaNova (NASDAQ:LIVN) and LeMaitre Vascular (NASDAQ:LMAT) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

LivaNova has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market.

LeMaitre Vascular has a net margin of 25.02% compared to LivaNova's net margin of 12.82%. LivaNova's return on equity of 16.35% beat LeMaitre Vascular's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	12.82%	16.35%	7.76%
LeMaitre Vascular	25.02%	15.63%	10.06%

97.6% of LivaNova shares are owned by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are owned by institutional investors. 0.4% of LivaNova shares are owned by insiders. Comparatively, 7.4% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, LeMaitre Vascular had 8 more articles in the media than LivaNova. MarketBeat recorded 14 mentions for LeMaitre Vascular and 6 mentions for LivaNova. LivaNova's average media sentiment score of 0.79 beat LeMaitre Vascular's score of 0.12 indicating that LivaNova is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral

LeMaitre Vascular has lower revenue, but higher earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.47B	3.03	-$242.47M	$3.38	23.91
LeMaitre Vascular	$249.60M	7.42	$57.73M	$2.85	28.41

LivaNova currently has a consensus price target of $83.50, indicating a potential upside of 3.30%. LeMaitre Vascular has a consensus price target of $110.60, indicating a potential upside of 36.61%. Given LeMaitre Vascular's higher probable upside, analysts clearly believe LeMaitre Vascular is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
LeMaitre Vascular	0 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.44

Summary

LivaNova beats LeMaitre Vascular on 9 of the 17 factors compared between the two stocks.

How does LeMaitre Vascular compare to Integer?

Integer (NYSE:ITGR) and LeMaitre Vascular (NASDAQ:LMAT) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

Integer has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market.

LeMaitre Vascular has a net margin of 25.02% compared to Integer's net margin of 6.97%. LeMaitre Vascular's return on equity of 15.63% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
LeMaitre Vascular	25.02%	15.63%	10.06%

In the previous week, LeMaitre Vascular had 6 more articles in the media than Integer. MarketBeat recorded 14 mentions for LeMaitre Vascular and 8 mentions for Integer. Integer's average media sentiment score of 0.65 beat LeMaitre Vascular's score of 0.12 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.30	$102.81M	$3.66	34.23
LeMaitre Vascular	$249.60M	7.42	$57.73M	$2.85	28.41

99.3% of Integer shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 7.4% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Integer presently has a consensus target price of $109.86, suggesting a potential downside of 12.32%. LeMaitre Vascular has a consensus target price of $110.60, suggesting a potential upside of 36.61%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
LeMaitre Vascular	0 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.44

Summary

LeMaitre Vascular beats Integer on 9 of the 16 factors compared between the two stocks.

How does LeMaitre Vascular compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and LeMaitre Vascular (NASDAQ:LMAT) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

84.6% of LeMaitre Vascular shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 7.4% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

LeMaitre Vascular has a net margin of 25.02% compared to iRhythm Technologies' net margin of -1.69%. LeMaitre Vascular's return on equity of 15.63% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
LeMaitre Vascular	25.02%	15.63%	10.06%

In the previous week, iRhythm Technologies had 20 more articles in the media than LeMaitre Vascular. MarketBeat recorded 34 mentions for iRhythm Technologies and 14 mentions for LeMaitre Vascular. iRhythm Technologies' average media sentiment score of 0.59 beat LeMaitre Vascular's score of 0.12 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	10 Very Positive mention(s)	5 Positive mention(s)	11 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
LeMaitre Vascular	1 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral

LeMaitre Vascular has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$825.34M	4.94	-$44.55M	-$0.43	N/A
LeMaitre Vascular	$249.60M	7.42	$57.73M	$2.85	28.41

iRhythm Technologies has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

iRhythm Technologies presently has a consensus price target of $179.93, indicating a potential upside of 45.37%. LeMaitre Vascular has a consensus price target of $110.60, indicating a potential upside of 36.61%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe iRhythm Technologies is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
LeMaitre Vascular	0 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.44

Summary

LeMaitre Vascular beats iRhythm Technologies on 9 of the 17 factors compared between the two stocks.

Get LeMaitre Vascular News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LMAT vs. The Competition

Export

Metric	LeMaitre Vascular	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.85B	$5.84B	$7.03B	$12.96B
Dividend Yield	1.23%	1.77%	2.58%	10.34%
P/E Ratio	28.41	24.94	268.76	25.28
Price / Sales	7.42	62.59	583.62	76.23
Price / Cash	27.98	33.38	72.26	50.42
Price / Book	4.40	5.80	13.15	6.23
Net Income	$57.73M	$148.67M	$3.45B	$347.51M
7 Day Performance	2.48%	1.73%	1.92%	1.38%
1 Month Performance	-21.20%	1.51%	-0.33%	-0.55%
1 Year Performance	-14.22%	8.51%	70.52%	21.00%

LeMaitre Vascular Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LMAT LeMaitre Vascular	4.7479 of 5 stars	$80.96 -2.3%	$110.60 +36.6%	-10.6%	$1.85B	$249.60M	28.41	490
TFX Teleflex	3.8884 of 5 stars	$139.75 +0.0%	$148.90 +6.5%	+15.3%	$6.18B	$1.99B	N/A	15,500	Earnings Report Analyst Upgrade
MMED MiniMed Group	2.597 of 5 stars	$18.94 -0.8%	$21.62 +14.1%	N/A	$5.32B	$3.10B	N/A	8,000	Gap Up
LIVN LivaNova	2.6462 of 5 stars	$82.65 +0.2%	$81.38 -1.5%	+58.6%	$4.54B	$1.39B	42.40	3,300	Positive News Earnings Report
ITGR Integer	2.3164 of 5 stars	$124.55 +0.1%	$109.86 -11.8%	+18.6%	$4.23B	$1.85B	31.06	11,000	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LMAT) was last updated on 8/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LeMaitre Vascular (LMAT) Competitors

LMAT vs. TFX, MMED, LIVN, ITGR, and IRTC

How does LeMaitre Vascular compare to Teleflex?

Summary

How does LeMaitre Vascular compare to MiniMed Group?

Summary

How does LeMaitre Vascular compare to LivaNova?

Summary

How does LeMaitre Vascular compare to Integer?

Summary

How does LeMaitre Vascular compare to iRhythm Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMAT vs. The Competition

LeMaitre Vascular Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LeMaitre Vascular (LMAT) Competitors

LMAT vs. TFX, MMED, LIVN, ITGR, and IRTC

How does LeMaitre Vascular compare to Teleflex?

Which has preferable earnings & valuation, LMAT or TFX?

Does the media prefer LMAT or TFX?

Do insiders and institutionals believe in LMAT or TFX?

Do analysts recommend LMAT or TFX?

Is LMAT or TFX a better dividend stock?

Which has more volatility and risk, LMAT or TFX?

Is LMAT or TFX more profitable?

Summary

How does LeMaitre Vascular compare to MiniMed Group?

Do analysts rate LMAT or MMED?

Does the media prefer LMAT or MMED?

Do institutionals & insiders hold more shares of LMAT or MMED?

Which has higher earnings & valuation, LMAT or MMED?

Is LMAT or MMED more profitable?

Summary

How does LeMaitre Vascular compare to LivaNova?

Which has more volatility and risk, LIVN or LMAT?

Is LIVN or LMAT more profitable?

Do institutionals and insiders believe in LIVN or LMAT?

Does the media prefer LIVN or LMAT?

Which has better earnings & valuation, LIVN or LMAT?

Do analysts prefer LIVN or LMAT?

Summary

How does LeMaitre Vascular compare to Integer?

Which has more volatility & risk, ITGR or LMAT?

Is ITGR or LMAT more profitable?

Does the media prefer ITGR or LMAT?

Which has preferable earnings and valuation, ITGR or LMAT?

Do institutionals and insiders have more ownership in ITGR or LMAT?

Do analysts recommend ITGR or LMAT?

Summary

How does LeMaitre Vascular compare to iRhythm Technologies?

Do institutionals and insiders believe in IRTC or LMAT?

Is IRTC or LMAT more profitable?

Does the media favor IRTC or LMAT?

Which has higher valuation and earnings, IRTC or LMAT?

Which has more risk & volatility, IRTC or LMAT?

Do analysts recommend IRTC or LMAT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMAT vs. The Competition

LeMaitre Vascular Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools